首页> 中文期刊> 《世界核心医学期刊文摘:妇产科学分册》 >化疗耐药性卵巢未成熟畸胎瘤接受补救手术后存活时间延长:病例报道及文献回顾

化疗耐药性卵巢未成熟畸胎瘤接受补救手术后存活时间延长:病例报道及文献回顾

         

摘要

Background. Data regarding salvage surgery for ovarian immature teratoma (IT) are lacking despite its established role in the management of chemorefractory testicular germ cell tumors. In this report, a case of advanced IT that was salvaged by secondary cytoreduction following failure of both primary therapy and salvage chemotherapy is described, and the available literature is reviewed. Case. A 28- year- old patient underwent primary cytoreductive surgery followed by platinum- based chemotherapy for stage IIIC, grade 3, ovarian IT. Second- line chemotherapy was administered after residual disease was identified at second- look surgery. Following failure of salvage chemotherapy, aggressive secondary debulking resulted in long- term diseasefree survival of over 48 months. Conclusion. There appears to be a distinct role for salvage surgery in selected cases of chemorefractory IT. More studies are needed to further define the subset of patients who benefit most from this management approach.

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号